<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e8417-2a15-72d0-a88a-88087aa76e30,g:af5ad5c6-69a5-470c-94c7-06716aa3560e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cntx-20260630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e8417-2a15-770d-9472-f0721f6b8af5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e8417-2a15-778d-9e75-1f8cd71043a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e8417-2a15-770d-9472-f0721f6b8af5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e8417-2a15-778d-9e75-1f8cd71043a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e8417-2a15-70ca-bdc6-a64c4fd4d1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e8417-2a15-770d-9472-f0721f6b8af5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e8417-2a15-70ca-bdc6-a64c4fd4d1d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e8417-2a15-769c-ad77-d1a4388d538c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e8417-2a15-7d1e-87aa-70788cf671ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e8417-2a15-769c-ad77-d1a4388d538c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e8417-2a15-7d1e-87aa-70788cf671ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e8417-2a15-70fd-be48-6c0aad418a13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e8417-2a15-769c-ad77-d1a4388d538c" xlink:to="loc_us-gaap_AssetsCurrent_019e8417-2a15-70fd-be48-6c0aad418a13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e8417-2a15-7986-a868-a46a1fd165b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e8417-2a15-769c-ad77-d1a4388d538c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e8417-2a15-7986-a868-a46a1fd165b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e8417-2a15-7f91-a41f-6339a1d40cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e8417-2a15-7596-8e9b-4e1f96e7b863" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e8417-2a15-7f91-a41f-6339a1d40cfb" xlink:to="loc_us-gaap_PreferredStockValue_019e8417-2a15-7596-8e9b-4e1f96e7b863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019e8417-2a15-78dc-b3d2-4206bd168f98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e8417-2a15-7f91-a41f-6339a1d40cfb" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019e8417-2a15-78dc-b3d2-4206bd168f98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e8417-2a15-7cbb-ab9f-b74a2ce41205" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e8417-2a15-7f91-a41f-6339a1d40cfb" xlink:to="loc_us-gaap_CommonStockValue_019e8417-2a15-7cbb-ab9f-b74a2ce41205" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e8417-2a15-7339-b578-2f538cf7760d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e8417-2a15-7f91-a41f-6339a1d40cfb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e8417-2a15-7339-b578-2f538cf7760d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e8417-2a15-7702-9c5c-361a4aaa85c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e8417-2a15-7c59-9fc7-ae34f830ea01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e8417-2a15-7702-9c5c-361a4aaa85c6" xlink:to="loc_us-gaap_Liabilities_019e8417-2a15-7c59-9fc7-ae34f830ea01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e8417-2a15-7ac3-9942-060119b93c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e8417-2a15-7702-9c5c-361a4aaa85c6" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e8417-2a15-7ac3-9942-060119b93c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e8417-2a15-71f8-aa78-563c1ab88912" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e8417-2a15-7702-9c5c-361a4aaa85c6" xlink:to="loc_us-gaap_StockholdersEquity_019e8417-2a15-71f8-aa78-563c1ab88912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e8417-2a15-7a26-aa5c-3aa0b6d6d139" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019e8417-2a15-744f-8605-8737b59562ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e8417-2a15-7a26-aa5c-3aa0b6d6d139" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019e8417-2a15-744f-8605-8737b59562ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e8417-2a15-7a48-beea-56919734c7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e8417-2a15-7a26-aa5c-3aa0b6d6d139" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e8417-2a15-7a48-beea-56919734c7ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019e8417-2a15-73b5-af12-fbedb329463d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e8417-2a15-7a26-aa5c-3aa0b6d6d139" xlink:to="loc_us-gaap_AccountsPayableCurrent_019e8417-2a15-73b5-af12-fbedb329463d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e8417-2a15-7618-b3be-d5596d198454" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e8417-2a15-752f-8c2d-9650d95ac2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e8417-2a15-7618-b3be-d5596d198454" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e8417-2a15-752f-8c2d-9650d95ac2c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e8417-2a15-7206-8d63-878c90389d84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e8417-2a15-7618-b3be-d5596d198454" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e8417-2a15-7206-8d63-878c90389d84" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cntx-20260630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-78cb-a01e-ab63529cfbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e8417-2a15-7f90-a83a-b648a7686fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-78cb-a01e-ab63529cfbdf" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019e8417-2a15-7f90-a83a-b648a7686fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019e8417-2a15-707e-a5c1-96dcb04501c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-78cb-a01e-ab63529cfbdf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019e8417-2a15-707e-a5c1-96dcb04501c8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/CondensedConsolidatedStatementofCashFlowsUnaudited" xlink:type="simple" xlink:href="cntx-20260630.xsd#CondensedConsolidatedStatementofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/CondensedConsolidatedStatementofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e8417-2a15-7796-bf33-221fd87f0ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e8417-2a15-76a4-a7c5-c016c80612b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e8417-2a15-7796-bf33-221fd87f0ae7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e8417-2a15-76a4-a7c5-c016c80612b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-79ae-810d-3721729c33d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e8417-2a15-7796-bf33-221fd87f0ae7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-79ae-810d-3721729c33d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e8417-2a15-7a82-879d-44a5b1d83601" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e8417-2a15-7796-bf33-221fd87f0ae7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e8417-2a15-7a82-879d-44a5b1d83601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e8417-2a15-753f-b6ff-b910ad291f04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e8417-2a15-7ecf-ab85-10c2f081d08d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e8417-2a15-753f-b6ff-b910ad291f04" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e8417-2a15-7ecf-ab85-10c2f081d08d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_019faecf-51c1-7210-bae2-540bb12b81f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e8417-2a15-753f-b6ff-b910ad291f04" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_019faecf-51c1-7210-bae2-540bb12b81f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e8417-2a15-7aed-82be-916f1911b566" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e8417-2a15-70ee-8b2b-476b38f7266e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e8417-2a15-7aed-82be-916f1911b566" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e8417-2a15-70ee-8b2b-476b38f7266e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019e8417-2a15-7cfd-a37c-1c7b194c842a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019e8417-2a15-7cfd-a37c-1c7b194c842a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_019faee1-f51f-78dc-9aeb-76d76c83a46a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_019faee1-f51f-78dc-9aeb-76d76c83a46a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e8417-2a15-75ac-aff3-cb6d69dbcace" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e8417-2a15-75ac-aff3-cb6d69dbcace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e8417-2a15-7422-b484-373787776aee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:to="loc_us-gaap_ShareBasedCompensation_019e8417-2a15-7422-b484-373787776aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e8417-2a15-785e-a3cf-1df2bf5e428b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:to="loc_us-gaap_NetIncomeLoss_019e8417-2a15-785e-a3cf-1df2bf5e428b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019e8417-2a15-70d4-9cd7-ecc6ef3b8822" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019e8417-2a15-70d4-9cd7-ecc6ef3b8822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019e8417-2a15-7fba-a4a1-7503857dcdee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019e8417-2a15-7fba-a4a1-7503857dcdee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e8417-2a15-7088-9209-3f7c82a478b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e8417-2a15-7088-9209-3f7c82a478b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e8417-2a15-7a98-8c54-25d0ea11c577" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e8417-2a15-7fc8-afc6-dd6ed7acc643" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e8417-2a15-7a98-8c54-25d0ea11c577" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesSummaryofSignificantExpenseCategoriesReviewedByTheCODMDetails" xlink:type="simple" xlink:href="cntx-20260630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesSummaryofSignificantExpenseCategoriesReviewedByTheCODMDetails"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesSummaryofSignificantExpenseCategoriesReviewedByTheCODMDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e8417-2a15-787a-b403-7fb77063795d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e8417-2a15-75e6-8572-156852f9616d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e8417-2a15-787a-b403-7fb77063795d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e8417-2a15-75e6-8572-156852f9616d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019e8417-2a15-70db-b037-96458b87facf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e8417-2a15-787a-b403-7fb77063795d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019e8417-2a15-70db-b037-96458b87facf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-790f-9a5f-bee62cb338fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e8417-2a15-787a-b403-7fb77063795d" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-790f-9a5f-bee62cb338fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-79d3-9ccb-6977258d1859" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e8417-2a15-7140-b4ba-64e7aa435d17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-79d3-9ccb-6977258d1859" xlink:to="loc_us-gaap_OperatingExpenses_019e8417-2a15-7140-b4ba-64e7aa435d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e8417-2a15-7497-9198-a2e924c777df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-79d3-9ccb-6977258d1859" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e8417-2a15-7497-9198-a2e924c777df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019e8417-2a15-7ea2-a82a-3b6dfe663a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-79d3-9ccb-6977258d1859" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019e8417-2a15-7ea2-a82a-3b6dfe663a7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019e8417-2a15-7f93-b3c0-fb5f93edaaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-79d3-9ccb-6977258d1859" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019e8417-2a15-7f93-b3c0-fb5f93edaaf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_019e8417-2a15-7b1b-bf61-8bf3432408ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e8417-2a15-79d3-9ccb-6977258d1859" xlink:to="loc_us-gaap_ProfessionalFees_019e8417-2a15-7b1b-bf61-8bf3432408ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="cntx-20260630.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.contexttherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019e8417-2a15-7f6b-8c91-06d49ca7eaef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cntx_AccruedResearchAndDevelopmentCostsCurrent_019e8417-2a15-7246-ae07-7be4b6a5f3aa" xlink:href="cntx-20260630.xsd#cntx_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e8417-2a15-7f6b-8c91-06d49ca7eaef" xlink:to="loc_cntx_AccruedResearchAndDevelopmentCostsCurrent_019e8417-2a15-7246-ae07-7be4b6a5f3aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e8417-2a15-77e4-aa78-b83563d41ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e8417-2a15-7f6b-8c91-06d49ca7eaef" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e8417-2a15-77e4-aa78-b83563d41ab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e8417-2a15-7c05-a045-bc32723915d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e8417-2a15-7f6b-8c91-06d49ca7eaef" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e8417-2a15-7c05-a045-bc32723915d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019e8417-2a15-7b1a-a37c-0c2ad316123a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e8417-2a15-7f6b-8c91-06d49ca7eaef" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019e8417-2a15-7b1a-a37c-0c2ad316123a" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
